Neurotoxic conversion of β-synuclein: A novel approach to generate a transgenic mouse model of synucleinopathies?

Journal of Neurology

Volumn 256, Issue SUPPL. 3, 2009, Pages

  Fujita, Masayo ^a   Sekigawa, Akio ^a   Sekiyama, Kazunari ^a   Sugama, Shuei ^a   Hashimoto, Makoto ^a  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; BETA SYNUCLEIN;

ASTROCYTOSIS; BRAIN DISEASE; BRAIN PROTECTION; CANCER CELL CULTURE; CLINICAL FEATURE; CONFERENCE PAPER; DEMENTIA; DIFFUSE LEWY BODY DISEASE; DISEASE MODEL; DOPAMINERGIC NERVE CELL; GENE MUTATION; GENE OVEREXPRESSION; HIPPOCAMPUS; HUMAN; MISSENSE MUTATION; NERVE DEGENERATION; NERVE FIBER; NEUROBLASTOMA; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN CONTENT; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; SYNUCLEINOPATHY; TRANSGENIC MOUSE; WILD TYPE;

ALPHA-SYNUCLEIN; ANIMALS; BETA-SYNUCLEIN; BRAIN; DISEASE MODELS, ANIMAL; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LEWY BODIES; LEWY BODY DISEASE; MICE; MUTATION, MISSENSE; PARKINSON DISEASE;

EID: 69549116416     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-009-5246-8     Document Type: Conference Paper

References (51)

1. M Baba S Nakajo PH Tu T Tomita K Nakaya VM Lee JQ Trojanowski T Iwatsubo 1998 Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies Am J Pathol 152 879 884 (Pubitemid 28173348)
2. R Betarbet TB Sherer JT Greenamyre 2002 Animal models of Parkinson's disease Bioessays 24 308 318
3. S Chandra G Gallardo R Fernandez-Chacon OM Schluter TC Sudhof 2005 Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration Cell 123 383 396
4. DF Clayton JM George 1999 Synucleins in synaptic plasticity and neurodegenerative disorders J Neurosci Res 58 120 129
5. KA Conway SJ Lee JC Rochet TT Ding RE Williamson PT Lansbury Jr 2000 Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy Proc Natl Acad Sci USA 97 571 576
6. Y Fan P Limprasert IV Murray AC Smith VM Lee JQ Trojanowski BL Sopher AR La Spada 2006 Beta-synuclein modulates alpha-synuclein neurotoxicity by reducing alpha-synuclein protein expression Hum Mol Genet 15 3002 3011
7. PO Fernagut MF Chesselet 2004 Alpha-synuclein and transgenic mouse models Neurobiol Dis 17 123 130
8. M Fujita S Sugama M Nakai T Takenouchi J Wei T Urano S Inoue M Hashimoto 2007 {Alpha}-synuclein stimulates differentiation of osteosarcoma cells: relevance to down-regulation of proteasome activity J Biol Chem 282 5736 5748
9. M Fujita J Wei M Nakai E Masliah M Hashimoto 2006 Chaperone and anti-chaperone: two-faced synuclein as stimulator of synaptic evolution Neuropathology 26 383 392
10. JE Galvin K Uryu VM Lee JQ Trojanowski 1999 Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein Proc Natl Acad Sci USA 96 13450 13455
11. BI Giasson JE Duda SM Quinn B Zhang JQ Trojanowski VM Lee 2002 Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein Neuron 34 521 533
12. EA Greenbaum CL Graves AJ Mishizen-Eberz MA Lupoli DR Lynch SW Englander PH Axelsen BI Giasson 2005 The E46K mutation in alpha-synuclein increases amyloid fibril formation J Biol Chem 280 7800 7807
13. M Hashimoto P Bar-On G Ho T Takenouchi E Rockenstein L Crews E Masliah 2004 Beta-synuclein regulates Akt activity in neuronal cells: A possible mechanism for neuroprotection in Parkinson's disease J Biol Chem 279 23622 23629
14. M Hashimoto E Masliah 1999 Alpha-synuclein in Lewy body disease and Alzheimer's disease Brain Pathol 9 707 720
15. M Hashimoto E Rockenstein M Mante L Crews P Bar-On FH Gage R Marr E Masliah 2004 An antiaggregation gene therapy strategy for Lewy body disease utilizing beta-synuclein lentivirus in a transgenic model Gene Ther 11 1713 1723
16. M Hashimoto E Rockenstein M Mante M Mallory E Masliah 2001 Beta-synuclein inhibits alpha-synuclein aggregation: a possible role as an anti-parkinsonian factor Neuron 32 213 223
17. M Hashimoto E Rockenstein E Masliah 2003 Transgenic models of alpha-synuclein pathology: past, present, and future Ann N Y Acad Sci 991 171 188
18. R Jakes MG Spillantini M Goedert 1994 Identification of two distinct synucleins from human brain FEBS Lett 345 27 32
19. H Ji YE Liu T Jia M Wang J Liu G Xiao BK Joseph C Rosen YE Shi 1997 Identification of a breast cancer-specific gene, BCSG1, by direct differential cDNA sequencing Cancer Res 57 759 764
20. PJ Kahle 2008 Alpha-synucleinopathy models and human neuropathology: similarities and differences Acta Neuropathol 115 87 95
21. R Kruger W Kuhn T Muller D Woitalla M Graeber S Kosel H Przuntek JT Epplen L Schols O Riess 1998 Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease Nat Genet 18 106 108
22. S Kuzuhara H Mori N Izumiyama M Yoshimura Y Ihara 1988 Lewy bodies are ubiquitinated. A light and electron microscopic immunocytochemical study Acta Neuropathol 75 345 353
23. D Lee SR Paik KY Choi 2004 Beta-synuclein exhibits chaperone activity more efficiently than alpha-synuclein FEBS Lett 576 256 260
24. MK Lee W Stirling Y Xu X Xu D Qui AS Mandir TM Dawson NG Copeland NA Jenkins DL Price 2002 Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 → Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice Proc Natl Acad Sci USA 99 8968 8973
25. E Masliah E Rockenstein I Veinbergs M Mallory M Hashimoto A Takeda Y Sagara A Sisk L Mucke 2000 Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders Science 287 1265 1269
26. S Nakajo K Tsukada K Omata Y Nakamura K Nakaya 1993 A new brain-specific 14-kDa protein is a phosphoprotein. Its complete amino acid sequence and evidence for phosphorylation Eur J Biochem 217 1057 1063
27. M Neumann PJ Kahle BI Giasson L Ozmen E Borroni W Spooren V Muller S Odoy H Fujiwara M Hasegawa T Iwatsubo JQ Trojanowski HA Kretzschmar C Haass 2002 Misfolded proteinase K-resistant hyperphosphorylated alpha-synuclein in aged transgenic mice with locomotor deterioration and in human alpha- synucleinopathies J Clin Invest 110 1429 1439
28. N Ninkina O Peters S Millership H Salem H van der Putten VL Buchman 2009 {Gamma}-synucleinopathy-neurodegeneration associated with overexpression of the mouse protein Hum Mol Genet 18 1779 1794
29. K Nishioka S Hayashi MJ Farrer AB Singleton H Yoshino H Imai T Kitami K Sato R Kuroda H Tomiyama K Mizoguchi M Murata T Toda I Imoto J Inazawa Y Mizuno N Hattori 2006 Clinical heterogeneity of alpha-synuclein gene duplication in Parkinson's disease Ann Neurol 59 298 309
30. H Ohtake P Limprasert Y Fan O Onodera A Kakita H Takahashi LT Bonner DW Tsuang IV Murray VM Lee JQ Trojanowski A Ishikawa J Idezuka M Murata T Toda TD Bird JB Leverenz S Tsuji AR La Spada 2004 Beta-synuclein gene alterations in dementia with Lewy bodies Neurology 63 805 811
31. JY Park PT Lansbury Jr 2003 Beta-synuclein inhibits formation of alpha-synuclein protofibrils: a possible therapeutic strategy against Parkinson's disease Biochemistry 42 3696 3700
32. MH Polymeropoulos C Lavedan E Leroy SE Ide A Dehejia A Dutra B Pike H Root J Rubenstein R Boyer ES Stenroos S Chandrasekharappa A Athanassiadou T Papapetropoulos WG Johnson AM Lazzarini RC Duvoisin G Di Iorio LI Golbe RL Nussbaum 1997 Mutation in the alpha-synuclein gene identified in families with Parkinson's disease Science 276 2045 2047
33. A Ramirez A Heimbach J Grundemann B Stiller D Hampshire LP Cid I Goebel AF Mubaidin AL Wriekat J Roeper A Al-Din AM Hillmer M Karsak B Liss CG Woods MI Behrens C Kubisch 2006 Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase Nat Genet 38 1184 1191
34. K Saigoh YL Wang JG Suh T Yamanishi Y Sakai H Kiyosawa T Harada N Ichihara S Wakana T Kikuchi K Wada 1999 Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice Nat Genet 23 47 51
35. Y Saito K Suzuki CM Hulette S Murayama 2004 Aberrant phosphorylation of alpha-synuclein in human Niemann-Pick type C1 disease J Neuropathol Exp Neurol 63 323 328
36. AB Singleton M Farrer J Johnson A Singleton S Hague J Kachergus M Hulihan T Peuralinna A Dutra R Nussbaum S Lincoln A Crawley M Hanson D Maraganore C Adler MR Cookson M Muenter M Baptista D Miller J Blancato J Hardy K Gwinn-Hardy 2003 Alpha-synuclein locus triplication causes Parkinson's disease Science 302 841
37. MG Spillantini RA Crowther R Jakes M Hasegawa M Goedert 1998 Alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies Proc Natl Acad Sci USA 95 6469 6473 (Pubitemid 28249037)
38. MG Spillantini ML Schmidt VM Lee JQ Trojanowski R Jakes M Goedert 1997 Alpha-synuclein in Lewy bodies Nature 388 839 840
39. K Suzuki E Iseki O Katsuse A Yamaguchi K Katsuyama I Aoki S Yamanaka K Kosaka 2003 Neuronal accumulation of alpha- and beta-synucleins in the brain of a GM2 gangliosidosis mouse model NeuroReport 14 551 554
40. A Takeda M Mallory M Sundsmo W Honer L Hansen E Masliah 1998 Abnormal accumulation of NACP/alpha-synuclein in neurodegenerative disorders Am J Pathol 152 367 372
41. JQ Trojanowski M Goedert T Iwatsubo VM Lee 1998 Fatal attractions: abnormal protein aggregation and neuron death in Parkinson's disease and Lewy body dementia Cell Death Differ 5 832 837
42. K Ueda H Fukushima E Masliah Y Xia A Iwai M Yoshimoto DA Otero J Kondo Y Ihara T Saitoh 1993 Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease Proc Natl Acad Sci USA 90 11282 11286
43. VN Uversky J Li P Souillac IS Millett S Doniach R Jakes M Goedert AL Fink 2002 Biophysical properties of the synucleins and their propensities to fibrillate: inhibition of alpha-synuclein assembly by beta- and gamma-synucleins J Biol Chem 277 11970 11978
44. H van der Putten KH Wiederhold A Probst S Barbieri C Mistl S Danner S Kauffmann K Hofele WP Spooren MA Ruegg S Lin P Caroni B Sommer M Tolnay G Bilbe 2000 Neuropathology in mice expressing human alpha-synuclein J Neurosci 20 6021 6029
45. K Wakabayashi M Yoshimoto S Tsuji H Takahashi 1998 Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy Neurosci Lett 249 180 182
46. YL Wang A Takeda H Osaka Y Hara A Furuta R Setsuie YJ Sun J Kwon Y Sato M Sakurai M Noda Y Yoshikawa K Wada 2004 Accumulation of beta- and gamma-synucleins in the ubiquitin carboxyl-terminal hydrolase L1-deficient gad mouse Brain Res 1019 1 9
47. J Wei M Fujita M Nakai M Waragai A Sekigawa S Sugama T Takenouchi E Masliah M Hashimoto 2009 Protective role of endogenous gangliosides for lysosomal pathology in a cellular model of synucleinopathies Am J Pathol 174 1891 1909
48. J Wei M Fujita M Nakai M Waragai K Watabe H Akatsu E Rockenstein E Masliah M Hashimoto 2007 Enhanced lysosomal pathology caused by beta-synuclein mutants linked to dementia with Lewy bodies J Biol Chem 282 28904 28914
49. CA Wilson DD Murphy BI Giasson B Zhang JQ Trojanowski VM Lee 2004 Degradative organelles containing mislocalized alpha-and beta-synuclein proliferate in presenilin-1 null neurons J Cell Biol 165 335 346
50. G Yamin LA Munishkina MA Karymov YL Lyubchenko VN Uversky AL Fink 2005 Forcing nonamyloidogenic beta-synuclein to fibrillate Biochemistry 44 9096 9107
51. JJ Zarranz J Alegre JC Gomez-Esteban E Lezcano R Ros I Ampuero L Vidal J Hoenicka O Rodriguez B Atares V Llorens E Gomez Tortosa T del Ser DG Munoz JG de Yebenes 2004 The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia Ann Neurol 55 164 173